MTBVAC Clinical Trials in India: A Pivotal Milestone with Global Implications

MTBVAC, the world’s first tuberculosis vaccine derived from a human source, has commenced clinical trials in India. This

Bharat Biotech, BIOFABRI Ink Pact to Develop Promising TB Vaccine, MTBVAC

BHARAT BIOTECH and BIOFABRI announced today their partnership to develop, manufacture and distribute a novel TB vaccine, MTBVAC.